Voluntary faculty are typically clinicians or others who are employed outside of the School but make significant contributions to department programs at the medical center or at affiliate institutions.
Voluntary rank detailsTerence Trow, MD
Associate Clinical ProfessorAbout
Copy Link
Biography
Dr. Trow has won a number of teaching awards including Attending of the Year at Danbury Hospital as well as Attending of the Year at Winthrop-University Hospital and has been appointed Fellow of the American College of Physicians and the American College of Chest Physicians. He served as a Deputy Editor of The Proceedings of the American Thoracic Society and served on the editorial board of Clinical Pulmonary Medicine. He is an invited reviewer for such journals as Annals of Internal Medicine, Chest, the American Journal of Respiratory and Critical Care Medicine, Heart & Lung, Southern Medical Journal, Clinical Pulmonary Medicine, and the Annals of the American Thoracic Society, Drug Design, Development and Therapy, and Thorax.. Dr. Trow also served on the Steering Committee for the Pulmonary Vascular Disease Network for the American College of Chest Physicians for seven years, as well as on the Steering Committee for the Scleroderma Foundation’s National Echocardiography Education Campaign. He was recently appointed to the Scientific Leadership Council of the Pulmonary Hypertension Association and was appointed to the ACCP Task force to update the ACCP Evidence-Based Guidelines in the Diagnosis and Management of Pulmonary Arterial Hypertension. Dr. Trow’s research interests are in the arena of clinical biomarkers in pulmonary hypertension as well as in combination therapy for the management of pulmonary arterial hypertension. He has published widely in such journals as Chest, the Proceedings of the American Thoracic Society, Clinical Pulmonary Medicine, the Journal of Biological Chemistry, Heart&Lung: The Journal of Acute Critical Care, the Journal of Immunology, the American Journal of Physiology, the American Journal of Medicine, and Thorax.
Dr. Trow received his A.B. degree from Bowdoin College graduating summa cum laude and Phi Beta Kappa with highest honors in Biochemistry in 1982. He subsequently matriculated at Dartmouth Medical School, earning his MD in 1986 after being elected to the Alpha Omega Alpha Society. After a year of internship at the Hospital of the University of Pennsylvania in Philadelphia he completed his internal medicine training at The New York Hospital of the Cornell University Medical College in 1989. After a brief period as a junior faculty member at Columbia College of Physicians and Surgeons in the Emergency Medicine Division, he pursued his fellowship training at Yale University in the Section of Pulmonary and Critical Care finishing in 1993. After 9 years of service at Danbury Hospital, where he was an integral member of the house staff teaching core faculty, he was recruited to establish and build the Pulmonary Hypertension Center at Winthrop-University Hospital in Mineola, NY, an affiliate of the State University of New York at Stony Brook from 2002-2005 before being recruited to do the same at Yale School of Medicine where he currently holds the title of Director of the Pulmonary Vascular Disease Program as well as Associate Professor of Medicine.
Appointments
Pulmonary, Critical Care & Sleep Medicine
Associate Clinical ProfessorPrimary
Other Departments & Organizations
- Internal Medicine
- Lysosomal Disease & Inherited Metabolic Liver Disease Program
- Pulmonary, Critical Care & Sleep Medicine
- Winchester Center for Lung Disease
- Yale Ventures
Education & Training
- Resident
- New York Hospital/Cornell University Medical Center (1989)
- Resident
- Hospital of the University of Pennsylvania (1987)
- MD
- Dartmouth School of Medicine (1986)
- BA
- Bowdoin College (1982)
Research
Copy Link
Overview
Medical Research Interests
Research at a Glance
Yale Co-Authors
Publications Timeline
Research Interests
Maor Sauler, MD
Robert Homer, MD, PhD
Ami Rubinowitz, MD
Robert I. White Jr, MD
Katharine Henderson
Mark David Siegel, MD
Hypertension, Pulmonary
Publications
2017
Tumor Emboli: A Rare Cause of Acute Pulmonary Hypertension
Mainardi A, Trow T. Tumor Emboli: A Rare Cause of Acute Pulmonary Hypertension. The American Journal Of Medicine 2017, 130: e137-e139. PMID: 28159185, DOI: 10.1016/j.amjmed.2016.11.023.Peer-Reviewed Original ResearchCitationsAltmetric
2014
Pharmacologic Therapy for Pulmonary Arterial Hypertension in Adults CHEST Guideline and Expert Panel Report
Taichman DB, Ornelas J, Chung L, Klinger JR, Lewis S, Mandel J, Palevsky HI, Rich S, Sood N, Rosenzweig EB, Trow TK, Yung R, Elliott CG, Badesch DB. Pharmacologic Therapy for Pulmonary Arterial Hypertension in Adults CHEST Guideline and Expert Panel Report. CHEST Journal 2014, 146: 449-475. PMID: 24937180, PMCID: PMC4137591, DOI: 10.1378/chest.14-0793.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsPulmonary arterial hypertensionHigh-level evidenceConsensus statementPharmacologic therapyAvailable evidenceArterial hypertensionGrades of RecommendationCochrane Library databasesExpert Panel ReportClinician adviceOptimal pharmacotherapyAdult patientsCHEST GuidelineGuideline recommendationsHigh-level recommendationsClinical questionsLibrary databasesSystematic reviewClinical decisionPharmacotherapyTherapyHypertensionEnglish-language evidenceLevel evidenceFurther studiesUnresolved pulmonary embolism leading to a diagnosis of pulmonary artery sarcoma
Gutiérrez A, Sauler M, Mitchell JM, Siegel MD, Trow TK, Bacchetta M, Fares WH. Unresolved pulmonary embolism leading to a diagnosis of pulmonary artery sarcoma. Heart & Lung 2014, 43: 574-576. PMID: 24928184, DOI: 10.1016/j.hrtlng.2014.05.006.Peer-Reviewed Case Reports and Technical NotesCitationsAltmetricMeSH Keywords and ConceptsConceptsPulmonary artery sarcomaPulmonary embolismPresumed pulmonary embolismUnresolved pulmonary embolismCT pulmonary angiogramAnticoagulation treatmentProgressive symptomsPulmonary angiogramSurgical resectionPulmonary arteryPoor prognosisRare tumorAdditional imagingDifferential diagnosisProper diagnosisEmbolismSarcomaDiagnosisResectionPatientsDyspneaArteryPrognosisAngiogramsMetastasis
2013
Preface
Trow TK. Preface. Clinics In Chest Medicine 2013, 34: xiii-xiv. PMID: 24267311, DOI: 10.1016/j.ccm.2013.10.009.Peer-Reviewed Original ResearchDiagnosis of Pulmonary Arterial Hypertension
Forfia PR, Trow TK. Diagnosis of Pulmonary Arterial Hypertension. Clinics In Chest Medicine 2013, 34: 665-681. PMID: 24267297, DOI: 10.1016/j.ccm.2013.09.001.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsPulmonary arterial hypertensionArterial hypertensionPulmonary venous hypertensionPopulation of patientsEchocardiographic cluesNonpharmacologic managementPulmonary hypertensionRight shuntingVenous hypertensionCardiac catheterizationClinical suspicionRight heartNoninvasive testsPhysical examLeft heartHigh indexHypertensionAccurate diagnosisDiagnosisCareful assessmentCatheterizationHeartPatientsShuntingSuspicionStandard Nonspecific Therapies in the Management of Pulmonary Arterial Hypertension
Sauler M, Fares WH, Trow TK. Standard Nonspecific Therapies in the Management of Pulmonary Arterial Hypertension. Clinics In Chest Medicine 2013, 34: 799-810. PMID: 24267305, DOI: 10.1016/j.ccm.2013.08.013.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCitationsMeSH Keywords and ConceptsConceptsHigh-dose calcium channel blockersCommon cardiopulmonary diseasesPAH-specific therapyPulmonary arterial hypertensionTreatment of patientsCalcium channel blockersPAH therapyArterial hypertensionAdjunct therapyOxygen therapyMedical therapyNonspecific therapyCardiopulmonary diseasePathologic understandingChannel blockersSmall studyTherapyHypertension researchExpert opinionAnticoagulationHypertensionDiureticsPatientsBlockersDigoxin
2012
IL-13 receptor α2-arginase 2 pathway mediates IL-13-induced pulmonary hypertension
Cho WK, Lee CM, Kang MJ, Huang Y, Giordano FJ, Lee PJ, Trow TK, Homer RJ, Sessa WC, Elias JA, Lee CG. IL-13 receptor α2-arginase 2 pathway mediates IL-13-induced pulmonary hypertension. American Journal Of Physiology - Lung Cellular And Molecular Physiology 2012, 304: l112-l124. PMID: 23125252, PMCID: PMC3543640, DOI: 10.1152/ajplung.00101.2012.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsPulmonary hypertensionIL-13Human pulmonary artery smooth muscle cellsDevelopment of PHPulmonary artery smooth muscle cellsRight ventricle systolic pressurePathogenesis of PHArtery smooth muscle cellsExpression of ARG2Pulmonary arterial hypertensionPulmonary vascular remodelingVentricle systolic pressurePotential therapeutic targetIL-13 treatmentSmooth muscle cellsNull mutant miceArterial hypertensionEffector cytokinesMedial thickeningSystolic pressureHemodynamic changesPulmonary arterySmall-interfering RNAVascular remodelingArginase-2Targeted approaches to the treatment of pulmonary hypertension
Fares WH, Trow TK. Targeted approaches to the treatment of pulmonary hypertension. Therapeutic Advances In Respiratory Disease 2012, 6: 147-159. PMID: 22438264, DOI: 10.1177/1753465812441849.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsPulmonary arterial hypertensionArterial hypertensionHigh-dose calcium channel blockersChest Physicians criteriaMultiple therapeutic optionsDurability of responseCalcium channel blockersTransplant evaluationPulmonary hypertensionOral therapyClose followPhysician's criteriaTherapeutic optionsChannel blockersEarly initiationAmerican CollegeHigh riskPatientsIncurable diseaseHypertensionEarly useStatus benefitsTreatmentDiseaseProgression
2011
Pregnancy and Pulmonary Hypertension
Lane CR, Trow TK. Pregnancy and Pulmonary Hypertension. Clinics In Chest Medicine 2011, 32: 165-174. PMID: 21277457, DOI: 10.1016/j.ccm.2010.10.006.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsReproducibility of Oxygen Saturation Monitoring During Six-Minute Walk Test and Exercise Stress Test in Patients with Pulmonary Arteriovenous Malformations Associated With Hereditary Hemorrhagic Telangiectasia
Li W, Niu B, Henderson K, Northrup V, Pollak JS, Trow T, Fahey J, White RI. Reproducibility of Oxygen Saturation Monitoring During Six-Minute Walk Test and Exercise Stress Test in Patients with Pulmonary Arteriovenous Malformations Associated With Hereditary Hemorrhagic Telangiectasia. Pediatric Cardiology 2011, 32: 590-594. PMID: 21336824, DOI: 10.1007/s00246-011-9917-8.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsPulmonary arteriovenous malformationsHereditary hemorrhagic telangiectasiaOxygen saturationHeart rateWalk testArteriovenous malformationsHemorrhagic telangiectasiaSix-minute walk testOxygen saturation monitoringLowest oxygen saturationYears of ageHuman Investigation CommitteeStress testIntraclass correlation coefficientAnatomic subtypesExercise capacityMultiple complicationsPatientsAdjunct testSaturation monitoringAdequate restReproducible measureMalformationsTelangiectasiaBroad spectrum
Academic Achievements & Community Involvement
Copy Link
Activities
activity National Scleroderma Foundation
06/01/2009 - 01/01/2012CommitteesCommittee MemberDetailsNational Scleroderma Foundation National Echo Education Campaignactivity American College of Chest Physicians
09/25/2004 - 11/03/2011Professional OrganizationsCommittee MemberDetailsPulmonary Vasuclar Disease Network
Honors
honor Alpha Omega Alpha Society
05/25/1986National AwardAlpha Omega AlphaDetailsUnited Stateshonor Phi Beta Kapp Member
05/25/1982National AwardPhi Beta Kappa SocietyDetailsUnited States
Get In Touch
Copy Link